ABT is a premiere beneficiary of ‘The Global Demographic Tailwind’ that I plan to hold for several years at least. I have high confidence in ABT’s management (the same team who ran the company before the ABBV spin-off), and I like ABT’s recent deals to bulk up in branded generics for emerging markets (#msg-102107675, #msg-103616483), which is a more profitable business than many investors think.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.